• Tuesday, Jan 25, 2022
  • Last Update : 03:32 am

Study: Pfizer shot declines faster than AstraZeneca

  • Published at 03:45 pm August 19th, 2021
Pfizer vaccine Covid
File photo: Vials labelled 'Covid-19 Coronavirus Vaccine' and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021 Reuters

The dynamics of immunity following second doses differed significantly" between Pfizer and AstraZeneca

The effectiveness of the Pfizer-BioNTech vaccine against Covid-19 declines faster than that of the AstraZeneca jab, according to a new study published on Thursday.

"Two doses of Pfizer-BioNTech have greater initial effectiveness against new COVID-19 infections, but this declines faster compared with two doses of Oxford-AstraZeneca," researchers at Oxford University said.

The study, which has not been peer reviewed, is based on the results of a survey by Britain's Office for National Statistics that carried out PCR tests from December last year to this month on randomly selected households.

It found that the dynamics of immunity following second doses differed significantly" between Pfizer and AstraZeneca, according to the university's Nuffield Department of Medicine.


Also Read - Lancet: Pfizer, AstraZeneca jab antibody levels may dip in 3 months


Pfizer had "greater initial effectiveness" but saw "faster declines in protection against high viral burden and symptomatic infection", when looking at a period of several months after full vaccination, although rates remained low for both jabs.

"Results suggest that after four to five months effectiveness of these two vaccines would be similar," the scientists added, while stressing that long-term effects need to be studied.

The study's findings come as Israel is administering booster shots, after giving 58 percent of the population two shots of the Pfizer jab.

The United States is also set to offer booster vaccines to boost antibody levels following concerns over declining effectiveness of the Pfizer and Moderna vaccines.


Also Read - Israel says Pfizer jab effectiveness dips to 39% amid Delta variant surge


The Oxford research also found that protection was higher among those who had already been infected with the virus.

The study examined two groups of more than 300,000 people over 18, first during the period dominated by the Alpha variant, which emerged in Kent, southeast England, and secondly from May 2021 onwards, when the Delta variant has been dominant. 

It confirmed that vaccines are less effective against Delta, which was first seen in India.

The AstraZeneca vaccine is the most widely offered in the UK, while those under 40 are offered Pfizer or Moderna due to blood clotting concerns.      

50
Facebook 50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail